Investors

The Financiers

Traditional venture capital bets everything on one company, one team, one outcome. Emergent offers something different: a portfolio approach to software products, modeled on how film studios finance slates of movies.

Slate I is our inaugural collection of products — a diversified portfolio where hits cover experiments, and the studio retains the IP that endures.

The Thesis

• Portfolio Diversification — Multiple products, multiple markets, multiple shots on goal
• Lower Risk Per Bet — Smaller checks across more products vs. one big swing
• IP Retention — The studio owns the franchises; value compounds over time
• Operational Leverage — Shared infrastructure, learnings, and talent across productions
• Darwin Framework — Products evolve based on market feedback, not founder stubbornness

Slate I Details

• Target — 10 products across B2B SaaS, consumer, and AI-native categories
• Funding Model — Details shared with qualified investors
• Timeline — 18-24 month production cycle for the slate
• Returns — Revenue share from successful products, plus potential exits

What We're Looking For

• Aligned Investors — You get the thesis and have patience for portfolio returns
• Value-Add Welcome — Operational expertise, distribution, or domain knowledge
• Accredited Investors — This is a private offering

What to Include in Your Inquiry

• Who You Are — Brief background (individual, family office, fund, etc.)
• Investment Capacity — Range you're considering
• What Interests You — Why this model? What sectors excite you?
• Value-Add — Beyond capital, what do you bring?

All investor communications are handled with discretion. We'll follow up with a detailed deck and next steps.